Detalhe da pesquisa
1.
IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses.
Int J Mol Sci
; 22(21)2021 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769278
2.
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.
Cancer Cell
; 40(12): 1470-1487.e7, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513049